Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Everest marks a new chapter in market confidence as Hong Kong Exchange grants removal of its “B” designation.

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...

mRNA vaccines achieved their first success against COVID-19, but could a bigger target be next? Ben Hargreaves examines whether the technology could provide a new tool against cancer, and how ...

A new ray of hope emerges from Russia with the development of a cancer vaccine that promises to eliminate tumors and metastasis.

Everest Medicines (HKEX 1952,“Everest”, or the“Company”), a biopharmaceutical company focused on the discovery, cl ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to cause pain or visible symptoms of illness. Several months from now, or perhaps ...